DWM
TEVA icon

Dynasty Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Dynasty Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+6,348
New +$211K ﹤0.01% 352
2026
Q1 		– Sell
-6,783
Closed -$212K – 382
2025
Q4 		$212K Buy
+6,783
New +$167K ﹤0.01% 325

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Dynasty Wealth Management's TEVA Position: Q2 2026 in Review

Dynasty Wealth Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 6,348 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #352 among its holdings. This is a return to the name: Dynasty Wealth Management previously reported a position in TEVA as recently as Q4 2025.

Dynasty Wealth Management first reported a position in TEVA in Q4 2025 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Dynasty Wealth Management held 6,348 shares of Teva Pharmaceuticals worth $215K as of Q2 2026.
  • Teva Pharmaceuticals was a new Dynasty Wealth Management position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #352 holding.
  • Dynasty Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.